Clinical trial
Differential Risks for Melanoma: p16 and DNA Repair
NCT00615095 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Differential Risks for Melanoma: p16 and DNA Repair
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 1997
- Completion date
- April 30, 2011
- Enrollment
- 323 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
melanoma, skin melanoma
Lead sponsor's other trials
Memorial Sloan Kettering Cancer Center, most recent start first.
+1,958 more trials See the organization page
Similar trials
Same condition (Melanoma) and phase, most recent start first.
+472 more trials See the condition page